First Report

U.S. Patient and Clinician Experiences With the inFlow™ Urinary Prosthesis for Permanent Urinary Retention in Women

Leanne Schimke, MSN, FNP-C, CRNP, CUNP; Kevin M. Connolly


Urol Nurs. 2020;40(2):61-73. 

In This Article


In terms of operating the Activator, I have found it best and beneficial to assess the patient for motivation, cognition, and hand strength/dexterity. Based on this assessment, if I feel there is a chance of success, I will initiate use of the inFlow. Most of the time, issues arise in the first week if the patient is hypersensitive to the device or has problems operating the Activator. If the device is not a better alternative for the patient, it can be easily and safely removed at any time, and she can simply resume her previous method of bladder drainage. My success with the inFlow has been only about 50%, which is similar to original clinical trial data (Chen et al., 2005), but the clinic time required as well as the risk to an unsuccessful patient are both minimal. On the other hand, trying the inFlow provides at least a 50% possibility of meaningfully increasing the patient's quality of life and decreasing the number of their UTIs.